 Sindwani et al. was the first to report effectiveness and safety of Arista as a hemostatic agent in otolaryngology demonstrating its application in controlling postoperative bleeding after endoscopic sinus surgery.7 Zhang et al. demonstrated success rate of 100 in the prevention of seromas in patients undergoing resection of malignant tumors in multiple locations, including the lower extremity.8 Arista was recently shown to be useful in reducing postoperative chest tube output and hemostasis time in patients undergoing cardiothoracic surgery.9 